KR20230161962A - 나이세리아 고노르호애의 치료 방법 및 재료 - Google Patents

나이세리아 고노르호애의 치료 방법 및 재료 Download PDF

Info

Publication number
KR20230161962A
KR20230161962A KR1020237031684A KR20237031684A KR20230161962A KR 20230161962 A KR20230161962 A KR 20230161962A KR 1020237031684 A KR1020237031684 A KR 1020237031684A KR 20237031684 A KR20237031684 A KR 20237031684A KR 20230161962 A KR20230161962 A KR 20230161962A
Authority
KR
South Korea
Prior art keywords
cycloheteroalkyl
compound
infection
alkyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237031684A
Other languages
English (en)
Korean (ko)
Inventor
파딘자레매드혼 브이. 라마찬드란
모하메드 셀림
Original Assignee
퍼듀 리서치 파운데이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 퍼듀 리서치 파운데이션 filed Critical 퍼듀 리서치 파운데이션
Publication of KR20230161962A publication Critical patent/KR20230161962A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020237031684A 2021-03-26 2022-03-23 나이세리아 고노르호애의 치료 방법 및 재료 Pending KR20230161962A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163166309P 2021-03-26 2021-03-26
US63/166,309 2021-03-26
PCT/US2022/021467 WO2022204231A2 (en) 2021-03-26 2022-03-23 Methods and materials for treatment of neisseria gonorrhoeae infection

Publications (1)

Publication Number Publication Date
KR20230161962A true KR20230161962A (ko) 2023-11-28

Family

ID=83398108

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237031684A Pending KR20230161962A (ko) 2021-03-26 2022-03-23 나이세리아 고노르호애의 치료 방법 및 재료

Country Status (8)

Country Link
US (1) US20250339401A1 (cg-RX-API-DMAC7.html)
EP (1) EP4313040A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024511945A (cg-RX-API-DMAC7.html)
KR (1) KR20230161962A (cg-RX-API-DMAC7.html)
CN (1) CN117396201A (cg-RX-API-DMAC7.html)
AU (1) AU2022244356A1 (cg-RX-API-DMAC7.html)
CA (1) CA3211535A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022204231A2 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023150719A1 (en) * 2022-02-03 2023-08-10 Purdue Research Foundation Alpha-methylene and aminomethyl lactones and lactams for treatment of clostridioides difficile infection (cdi)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005500289A (ja) * 2001-06-13 2005-01-06 マグナケム インターナショナル ラボラトリーズ, インコーポレイテッド ラクトン処方物および使用方法
BRPI0620157A2 (pt) * 2005-12-15 2011-12-20 Activbiotics Pharma Llc usos de rifamicinas
US20210317099A1 (en) * 2020-04-09 2021-10-14 Purdue Research Foundation Safer, potent, and fast acting antimicrobial agents

Also Published As

Publication number Publication date
WO2022204231A3 (en) 2022-12-29
CA3211535A1 (en) 2022-09-29
CN117396201A (zh) 2024-01-12
WO2022204231A2 (en) 2022-09-29
US20250339401A1 (en) 2025-11-06
EP4313040A2 (en) 2024-02-07
AU2022244356A1 (en) 2023-09-28
EP4313040A4 (en) 2025-02-12
JP2024511945A (ja) 2024-03-18

Similar Documents

Publication Publication Date Title
US20210317099A1 (en) Safer, potent, and fast acting antimicrobial agents
CN1416428A (zh) 具有抗肿瘤活性的化合物、其制备方法以及含有该化合物的药物组合物
CN109923110A (zh) 苔藓抑素化合物和其制备方法
US20220226284A1 (en) Methods for the treatment of mycobacterium infections
KR20180108675A (ko) 브로모도메인 억제제인 카르볼린 유도체
CN116283939B (zh) 一种具有光响应活性的抗真菌化合物及其应用
US20250339401A1 (en) Methods and materials for treatment of neisseria gonorrhoeae infection
FR2801310A1 (fr) NOUVEAUX DERIVES DE DIHYDROFURO-[3,4-b]QUINOLEIN-1-ONES, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT
KR102650441B1 (ko) 내부 사이클릭 설피아미딘 아미드-아릴 아미드 화합물 및 이의 b형 간염 치료를 위한 용도
CN118406042B (zh) 含吡啶环的两亲性蛇床子素-季铵盐杂合体及其制备方法和抗菌应用
US7250438B2 (en) Anti-bacterial and anti-cancer spiro beta-lactone/gamma-lactams
US8653283B2 (en) Anticancer agents
JP4769726B2 (ja) コンセントリコリド及びその誘導体、それらを調製する工程、それを含む薬学的組成物並びにその使用
Diwakar et al. Synthesis, X-ray characterization and biological evaluation of some new 2-(4-methy-2-oxo-2 H-chromen-7yloxy) acetamide derivatives
CN112851561A (zh) 一种nr6a1蛋白受体抑制剂及其制备和应用
US20060111420A1 (en) Sorbicillactone-a derivatives for the treatment of tumour and viral diseases
JP2002535276A (ja) 4−デメチルペンクロメジンのアシル誘導体、その使用及び調製
US20250195490A1 (en) Alpha-methylene and aminomethyl lactones and lactams for treatment of clostridioides difficile infection (cdi)
CN113387808B (zh) Tagalsin C二萜衍生物及其制备和用途
CN114507139B (zh) 环丙烷类化合物及其制备方法与抗流感病毒的应用
CN115141204B (zh) 一种萘[1,2-b]呋喃-4,5-二酮衍生物其制备及其用途
Baker et al. Methods for the treatment of Mycobacterium infections
Chang et al. Synthesis, Anticancer Evaluation and Structure–Activity Relationship of Taiwanin a Derivatives
JP6359409B2 (ja) トール様受容体4活性化作用を有するフニクロシン誘導体及びその用途
Shinonaga et al. 13-Bromomonocillin I: a new WNT-5A expression inhibitor produced by Pochonia chlamydosporia var. chlamydosporia

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20230915

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20250313

Comment text: Request for Examination of Application